Want to see AU:PAR full AI Analyst Report?
Paradigm Biopharmaceuticals (PAR) Income Statement
Paradigm Biopharmaceuticals Income Statement
Last quarter (Q4 2026), Paradigm Biopharmaceuticals's total revenue was $55.00K, a decrease of 16.41% from the same quarter last year. In Q4, Paradigm Biopharmaceuticals's net income was $-33.09M. See Paradigm Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 80.15K | $ 52.12K | $ 65.80K | $ 46.76K | $ 79.22K | |
| $ -82.37K | $ -19.89K | $ 56.81K | $ -18.83K | $ -64.53K | |
| $ 61.03M | $ 22.87M | $ 65.10M | $ 60.07M | $ 47.93M | |
| Depreciation and Amortization | $ 150.39K | $ 51.42K | $ 146.74K | $ 153.66K | $ 193.25K |
| $ -60.96M | $ -25.25M | $ -64.54M | $ -59.06M | $ -46.82M | |
| $ -61.11M | $ -22.89M | $ -65.19M | $ -59.22M | $ -47.01M | |
| $ -2.84M | $ -2.42M | $ 6.54M | $ 263.61K | $ -1.48K | |
| $ -63.95M | $ -25.30M | $ -58.65M | $ -58.95M | $ -47.01M | |
| $ -56.33M | $ -18.77M | $ -58.65M | $ -51.91M | $ -39.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.15 | $ -0.06 | $ -0.20 | $ -0.18 | $ -0.16 |
| Diluted EPS | $ -0.15 | $ -0.06 | $ -0.20 | $ -0.18 | $ -0.16 |
| Weighted Average Shares Outstanding | 370.03M | 314.50M | 293.28M | 289.68M | 240.96M |
| Weighted Average Shares Outstanding (Diluted) | 370.03M | 314.50M | 293.28M | 289.68M | 241.82M |
Currency in AUD